Eccrine syringosquamous metaplasia (Q90209): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank

Revision as of 17:09, 15 August 2026

Eccrine syringosquamous metaplasia describes a distinctive microscopic finding of eccrine duct damage in which an insult, most commonly cytotoxic chemotherapy, has resulted in a transformation from the normal cuboidal to squamous epithelium, which may simulate squamous cell carcinoma. Patients present with erythematous papules, often in a generalised distribution and sometimes with vesicles and pustules. It may also present with acral erythema. Drugs implicated include cytarabine, doxorubicin, cis-platinum and protein kinase inhibitors.
Language Label Description Also known as
default for all languages
ID_407987403
    English
    Eccrine syringosquamous metaplasia
    Eccrine syringosquamous metaplasia describes a distinctive microscopic finding of eccrine duct damage in which an insult, most commonly cytotoxic chemotherapy, has resulted in a transformation from the normal cuboidal to squamous epithelium, which may simulate squamous cell carcinoma. Patients present with erythematous papules, often in a generalised distribution and sometimes with vesicles and pustules. It may also present with acral erythema. Drugs implicated include cytarabine, doxorubicin, cis-platinum and protein kinase inhibitors.

      Statements

      CID11:ID_407987403
      0 references
      dki-india-ID_407987403
      0 references
      Concluído
      0 references